Literature DB >> 15865935

The multiple roles of p53 in the pathogenesis of HIV associated dementia.

Gwenn A Garden1, Richard S Morrison.   

Abstract

The mechanism by which infection with the human immunodeficiency virus (HIV) leads to injury and dysfunction within the central nervous system (CNS) is not completely understood. Most studies support the hypothesis that neurons are impacted as bystander cells in a tissue environment made hostile by the innate and adaptive immune responses to chronic HIV infection within CNS tissue. The tumor suppressor transcription factor p53 participates in multiple cellular processes within the HIV infected CNS, and experimental evidence suggests that the resulting neurodegeneration occurs by induction of p53-mediated apoptotic pathways. Here we review the evidence for p53 as a participant in the responses of multiple CNS cell types to the presence of HIV and propose the hypothesis that HIV induced alterations in the CNS extracellular milieu converge at neuronal p53 activation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15865935     DOI: 10.1016/j.bbrc.2005.03.185

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Host and viral factors influencing the pathogenesis of HIV-associated neurocognitive disorders.

Authors:  Suman Jayadev; Gwenn A Garden
Journal:  J Neuroimmune Pharmacol       Date:  2009-04-17       Impact factor: 4.147

Review 2.  Role of p53 in neurodegenerative diseases.

Authors:  J Robert Chang; Mohammad Ghafouri; Ruma Mukerjee; Asen Bagashev; Tinatin Chabrashvili; Bassel E Sawaya
Journal:  Neurodegener Dis       Date:  2011-10-28       Impact factor: 2.977

Review 3.  Novel HIV-1 therapeutics through targeting altered host cell pathways.

Authors:  William Coley; Kylene Kehn-Hall; Rachel Van Duyne; Fatah Kashanchi
Journal:  Expert Opin Biol Ther       Date:  2009-11       Impact factor: 4.388

4.  Transcription factor p53 influences microglial activation phenotype.

Authors:  Suman Jayadev; Nicole K Nesser; Stephanie Hopkins; Scott J Myers; Amanda Case; Rona J Lee; Luke A Seaburg; Takuma Uo; Sean P Murphy; Richard S Morrison; Gwenn A Garden
Journal:  Glia       Date:  2011-05-19       Impact factor: 7.452

5.  9-Aminoacridine inhibition of HIV-1 Tat dependent transcription.

Authors:  Irene Guendel; Lawrence Carpio; Rebecca Easley; Rachel Van Duyne; William Coley; Emmanuel Agbottah; Cynthia Dowd; Fatah Kashanchi; Kylene Kehn-Hall
Journal:  Virol J       Date:  2009-07-24       Impact factor: 4.099

6.  HIV-1-infected astrocytes and the microglial proteome.

Authors:  Tong Wang; Nan Gong; Jianuo Liu; Irena Kadiu; Stephanie D Kraft-Terry; Joshua D Schlautman; Pawel Ciborowski; David J Volsky; Howard E Gendelman
Journal:  J Neuroimmune Pharmacol       Date:  2008-06-28       Impact factor: 4.147

7.  A Novel Role of Proline Oxidase in HIV-1 Envelope Glycoprotein-induced Neuronal Autophagy.

Authors:  Jui Pandhare; Sabyasachi Dash; Bobby Jones; Fernando Villalta; Chandravanu Dash
Journal:  J Biol Chem       Date:  2015-09-01       Impact factor: 5.157

8.  An integrated systems analysis implicates EGR1 downregulation in simian immunodeficiency virus encephalitis-induced neural dysfunction.

Authors:  Merril Gersten; Mehrdad Alirezaei; Maria Cecilia Garibaldi Marcondes; Claudia Flynn; Timothy Ravasi; Trey Ideker; Howard S Fox
Journal:  J Neurosci       Date:  2009-10-07       Impact factor: 6.167

9.  Involvement of the p53 and p73 transcription factors in neuroAIDS.

Authors:  Ruma Mukerjee; Satish L Deshmane; Shongshan Fan; Luis Del Valle; Martyn K White; Kamel Khalili; Shohreh Amini; Bassel E Sawaya
Journal:  Cell Cycle       Date:  2008-09-17       Impact factor: 4.534

Review 10.  Molecular mechanisms and clinical implications of reversible protein S-glutathionylation.

Authors:  John J Mieyal; Molly M Gallogly; Suparna Qanungo; Elizabeth A Sabens; Melissa D Shelton
Journal:  Antioxid Redox Signal       Date:  2008-11       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.